Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
Congenital myasthenic syndromes (CMS) are inherited disorders that lead to abnormal neuromuscular transmission. Post-synaptic mutations are the main cause of CMS, particularly mutations in CHRNE. We report a novel homozygous CHRNE pathogenic variant in two Egyptian siblings showing a CMS. Interestin...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.909715/full |
_version_ | 1818264663086858240 |
---|---|
author | Marta Gómez-García de la Banda Marta Gómez-García de la Banda Marta Gómez-García de la Banda Emmanuel Simental-Aldaba Emmanuel Simental-Aldaba Nagia Fahmy Damien Sternberg Damien Sternberg Patricia Blondy Susana Quijano-Roy Susana Quijano-Roy Susana Quijano-Roy Susana Quijano-Roy Edoardo Malfatti Edoardo Malfatti Edoardo Malfatti Edoardo Malfatti |
author_facet | Marta Gómez-García de la Banda Marta Gómez-García de la Banda Marta Gómez-García de la Banda Emmanuel Simental-Aldaba Emmanuel Simental-Aldaba Nagia Fahmy Damien Sternberg Damien Sternberg Patricia Blondy Susana Quijano-Roy Susana Quijano-Roy Susana Quijano-Roy Susana Quijano-Roy Edoardo Malfatti Edoardo Malfatti Edoardo Malfatti Edoardo Malfatti |
author_sort | Marta Gómez-García de la Banda |
collection | DOAJ |
description | Congenital myasthenic syndromes (CMS) are inherited disorders that lead to abnormal neuromuscular transmission. Post-synaptic mutations are the main cause of CMS, particularly mutations in CHRNE. We report a novel homozygous CHRNE pathogenic variant in two Egyptian siblings showing a CMS. Interestingly, they showed different degrees of extraocular and skeletal muscle involvement; both presented only a partial response to cholinesterase inhibitors, and rapidly and substantially ameliorated after the addition of oral β2 adrenergic agonists. Here, we enlarge the genetic spectrum of CHRNE-related congenital myasthenic syndromes and highlight the importance of a β2 adrenergic agonists treatment. |
first_indexed | 2024-12-12T19:38:29Z |
format | Article |
id | doaj.art-2d021aa9abe64deb8d77e3147c6f7f0a |
institution | Directory Open Access Journal |
issn | 1664-2295 |
language | English |
last_indexed | 2024-12-12T19:38:29Z |
publishDate | 2022-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Neurology |
spelling | doaj.art-2d021aa9abe64deb8d77e3147c6f7f0a2022-12-22T00:14:15ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-06-011310.3389/fneur.2022.909715909715Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian SiblingsMarta Gómez-García de la Banda0Marta Gómez-García de la Banda1Marta Gómez-García de la Banda2Emmanuel Simental-Aldaba3Emmanuel Simental-Aldaba4Nagia Fahmy5Damien Sternberg6Damien Sternberg7Patricia Blondy8Susana Quijano-Roy9Susana Quijano-Roy10Susana Quijano-Roy11Susana Quijano-Roy12Edoardo Malfatti13Edoardo Malfatti14Edoardo Malfatti15Edoardo Malfatti16Pediatric Neurology and ICU Department, AP-HP Université Paris Saclay, Hôpital Raymond Poincaré, Garches, FranceReference Center for Neuromuscular Diseases Centre “Nord- Est- Ile de France”, FILNEMUS, Creteil, FranceEuropean Reference Center Network (Euro-NMD ERN), Paris, FranceAPHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor University Hospital, Créteil, FranceDepartment of Neurorehabilitation, Instituto Nacional de Rehabilitación “LGII”, Mexico City, MexicoNeuromuscular Unit, Faculty of Medicine, Ain Shams University, Cairo, EgyptEuropean Reference Center Network (Euro-NMD ERN), Paris, FranceService de Biochimie Métabolique, Centre de Génétique, Groupe Hospitalier Pitié-Salpêtrière, APHP Sorbonne Université, Paris, FranceEuropean Reference Center Network (Euro-NMD ERN), Paris, FrancePediatric Neurology and ICU Department, AP-HP Université Paris Saclay, Hôpital Raymond Poincaré, Garches, FranceReference Center for Neuromuscular Diseases Centre “Nord- Est- Ile de France”, FILNEMUS, Creteil, FranceEuropean Reference Center Network (Euro-NMD ERN), Paris, FranceCentre de Recherche en Myologie, UMRS974, Paris, FranceReference Center for Neuromuscular Diseases Centre “Nord- Est- Ile de France”, FILNEMUS, Creteil, FranceAPHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor University Hospital, Créteil, FranceUniv Paris Est Créteil, INSERM, IMRB, Créteil, France0AP-HP, Hôpital Mondor, Service d'histologie, Créteil, FranceCongenital myasthenic syndromes (CMS) are inherited disorders that lead to abnormal neuromuscular transmission. Post-synaptic mutations are the main cause of CMS, particularly mutations in CHRNE. We report a novel homozygous CHRNE pathogenic variant in two Egyptian siblings showing a CMS. Interestingly, they showed different degrees of extraocular and skeletal muscle involvement; both presented only a partial response to cholinesterase inhibitors, and rapidly and substantially ameliorated after the addition of oral β2 adrenergic agonists. Here, we enlarge the genetic spectrum of CHRNE-related congenital myasthenic syndromes and highlight the importance of a β2 adrenergic agonists treatment.https://www.frontiersin.org/articles/10.3389/fneur.2022.909715/fullcongenital myasthenic syndromeCHRNEneuromuscular junctionβ2 adrenergic agonistssalbutamol |
spellingShingle | Marta Gómez-García de la Banda Marta Gómez-García de la Banda Marta Gómez-García de la Banda Emmanuel Simental-Aldaba Emmanuel Simental-Aldaba Nagia Fahmy Damien Sternberg Damien Sternberg Patricia Blondy Susana Quijano-Roy Susana Quijano-Roy Susana Quijano-Roy Susana Quijano-Roy Edoardo Malfatti Edoardo Malfatti Edoardo Malfatti Edoardo Malfatti Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings Frontiers in Neurology congenital myasthenic syndrome CHRNE neuromuscular junction β2 adrenergic agonists salbutamol |
title | Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings |
title_full | Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings |
title_fullStr | Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings |
title_full_unstemmed | Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings |
title_short | Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings |
title_sort | case report a novel achr epsilon variant causing a clinically discordant salbutamol responsive congenital myasthenic syndrome in two egyptian siblings |
topic | congenital myasthenic syndrome CHRNE neuromuscular junction β2 adrenergic agonists salbutamol |
url | https://www.frontiersin.org/articles/10.3389/fneur.2022.909715/full |
work_keys_str_mv | AT martagomezgarciadelabanda casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT martagomezgarciadelabanda casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT martagomezgarciadelabanda casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT emmanuelsimentalaldaba casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT emmanuelsimentalaldaba casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT nagiafahmy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT damiensternberg casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT damiensternberg casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT patriciablondy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings |